BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4995 related articles for article (PubMed ID: 1873853)

  • 1. Growth factors and tyrosine protein kinases in normal and malignant melanocytes.
    Halaban R
    Cancer Metastasis Rev; 1991 Jun; 10(2):129-40. PubMed ID: 1873853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes.
    Halaban R; Fan B; Ahn J; Funasaka Y; Gitay-Goren H; Neufeld G
    J Immunother (1991); 1992 Oct; 12(3):154-61. PubMed ID: 1445804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.
    Funasaka Y; Boulton T; Cobb M; Yarden Y; Fan B; Lyman SD; Williams DE; Anderson DM; Zakut R; Mishima Y
    Mol Biol Cell; 1992 Feb; 3(2):197-209. PubMed ID: 1372524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; Funasaka Y; Cobb M; Boulton T; Faletto D; Rosen E; Chan A; Yoko K; White W
    Oncogene; 1992 Nov; 7(11):2195-206. PubMed ID: 1331934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
    Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
    Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
    Zakut R; Perlis R; Eliyahu S; Yarden Y; Givol D; Lyman SD; Halaban R
    Oncogene; 1993 Aug; 8(8):2221-9. PubMed ID: 7687762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factors and melanomas.
    Halaban R
    Semin Oncol; 1996 Dec; 23(6):673-81. PubMed ID: 8970586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor.
    Natali PG; Nicotra MR; Winkler AB; Cavaliere R; Bigotti A; Ullrich A
    Int J Cancer; 1992 Sep; 52(2):197-201. PubMed ID: 1381702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
    Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
    Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. met and HGF-SF in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; White W
    EXS; 1993; 65():329-39. PubMed ID: 8380740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation and neoplastic transformation of pigment cells in metallothionein/ret transgenic mice.
    Takahashi M; Iwamoto T; Nakashima I
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):344-7. PubMed ID: 1292018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes.
    Mattei S; Colombo MP; Melani C; Silvani A; Parmiani G; Herlyn M
    Int J Cancer; 1994 Mar; 56(6):853-7. PubMed ID: 7509778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation and malignant transformation of melanocytes.
    Halaban R; Moellmann G
    Crit Rev Oncog; 1991; 2(4):247-58. PubMed ID: 1958709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression.
    Graeven U; Herlyn M
    J Immunother (1991); 1992 Oct; 12(3):199-202. PubMed ID: 1445812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth control of melanoma cells and melanocytes by cytokines.
    Krasagakis K; Garbe C; Zouboulis CC; Orfanos CE
    Recent Results Cancer Res; 1995; 139():169-82. PubMed ID: 7597288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological characterization of human fibroblast-derived mitogenic factors for human melanocytes.
    Imokawa G; Yada Y; Morisaki N; Kimura M
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1235-9. PubMed ID: 9494091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of placenta growth factor in human melanocytic cell lines.
    Graeven U; Rodeck U; Karpinski S; Jost M; Andre N; Schmiegel W
    J Invest Dermatol; 2000 Jul; 115(1):118-23. PubMed ID: 10886518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization.
    Scott G; Stoler M; Sarkar S; Halaban R
    J Invest Dermatol; 1991 Mar; 96(3):318-22. PubMed ID: 2002252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes.
    Lee ST; Strunk KM; Spritz RA
    Oncogene; 1993 Dec; 8(12):3403-10. PubMed ID: 8247543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bFGF is the putative natural growth factor for human melanocytes.
    Halaban R; Ghosh S; Baird A
    In Vitro Cell Dev Biol; 1987 Jan; 23(1):47-52. PubMed ID: 3027025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 250.